Showing Latest Articles
Merck Resumes Distribution of Monovalent Hib Vaccine.
Recall of PedvaxHIB Led to Nationwide Shortage, Booster Deferrals Full Text
American Family Physician, 02/15/2010
Merck & Co. Inc. has announced that PedvaxHIB, the manufacturer's monovalent Haemophilus influenzae type b, or Hib, conjugate vaccine is back on the market after an absence of more than two years. Merck recalled about 1 million doses of its Hib vaccines – PedvaxHIB and the combination Hib/hepatitis B vaccine COMVAX – in December 2007 after routine testing of equipment used to manufacture the vaccines identified the presence of the pathogen Bacillus cereus.
